BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//European Brain Council (EBC) - ECPv6.15.19//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.braincouncil.eu
X-WR-CALDESC:Events for European Brain Council (EBC)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20170101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180417
DTEND;VALUE=DATE:20180419
DTSTAMP:20260415T181337
CREATED:20200311T101943Z
LAST-MODIFIED:20200311T101943Z
UID:20239-1523923200-1524095999@www.braincouncil.eu
SUMMARY:4th Academy of National Brain Councils
DESCRIPTION:This year’s Academy of National Brain Councils will take place in Lisbon\, Portugal on 17-18 April. \nAcademy and TINA agenda
URL:https://www.braincouncil.eu/event/4th-academy-of-national-brain-councils/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180423
DTEND;VALUE=DATE:20180424
DTSTAMP:20260415T181337
CREATED:20200311T101911Z
LAST-MODIFIED:20200311T101911Z
UID:20237-1524441600-1524527999@www.braincouncil.eu
SUMMARY:Brain Research in Europe: Shaping FP9 and Delivering Innovation to the Benefit of Patients
DESCRIPTION:On April 23-24 2018\, EBC will hold a two day event focused on the shaping of the 9th Framework Programme\, Innovative medicine and global initiatives. The event will take place in 3 separate sessions: FP9 & Missions\, “The Value of Innovation” and “Brain Research: Shifting Gears and Going Global” \nInvestments into research and innovation have delivered unprecedented results for patients across Europe. Publicly and privately funded innovation schemes in the EU empowered researchers to accelerate scientific discovery\, increase the understanding of non-communicable diseases and improve healthcare services. Yet despite the progress that was achieved in recent decades\, there is currently no effective treatment to cure a wide range of mental and neurological conditions. What is more\, the complexity of many brain disorders hinders researchers in their efforts to develop innovative healthcare interventions. \nIn 2018\, the European Commission is expected to submit proposals for a mission-oriented and impact-focused 9th Framework Programme. In view of the preparations for the forthcoming EU research scheme\, the European Brain Council (EBC) aims to bring attention to the current barriers that affect therapeutic innovation and facilitate an exchange of views on how the post-2020 Framework Programme can make a real difference for patients living with brain disorders. \nThe event\, which consists of three individual sessions\, will allow leading healthcare stakeholders and policymakers to address key questions in the domain of research\, such as: how can the 9th Framework Programme accelerate brain research across Europe? What measures can be taken in order to stimulate the development of new central nervous system drugs for treating brain disorders? What can be done to address the concerns of patients? \nProgramme - Brain Research in Europe - 23-24 April
URL:https://www.braincouncil.eu/event/brain-research-in-europe-shaping-fp9-and-delivering-innovation-to-the-benefit-of-patients/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180425
DTEND;VALUE=DATE:20180426
DTSTAMP:20260415T181337
CREATED:20200311T101837Z
LAST-MODIFIED:20200311T101837Z
UID:20235-1524614400-1524700799@www.braincouncil.eu
SUMMARY:National Workshop on Off-label Use of Medicines: Declaración sobre buenas prácticas del uso fuera de guía de medicamentos en España - 25th April 2018
DESCRIPTION:The Spanish Brain Council (SBC)\, in cooperation with the European Brain Council (EBC)\, will hold the workshop “Declaración sobre buenas prácticas del uso fuera de guía de medicamentos en España” on 25th April in Madrid. \nOrganized against the backdrop of the Good Off-Label Use Practice (GOLUP) campaign\, this workshop aims to raise awareness of the 5 principles laid down in the GOLUP-declaration and facilitate an exchange of views amongst policy-makers and healthcare stakeholder on issues related to off-label use in Spain. The forthcoming event in Madrid is the second national workshop organized in the context of EBC’s advocacy work on off-label use of medicines. \nThe European Commission’s “Study on off-label use of medicinal products in the European Union” released in February 2017 indicated that the use of medicines off-label is a widespread phenomenon across Europe. Off-label use of medicines\, i.e. the practice of using a medicine outside its authorised indication\, for another patient group or in a different dose\, can offer solutions in areas of unmet medical needs but also presents challenges related to therapeutic innovation\, patient safety and professional liability. \nIn view of this and in order to provide further clarify on when medicinal products can be safely prescribed off-label\, EBC as well as 12 other organizations have endorsed the GOLUP-declaration. This document calls on regulators to adopt guidelines on the practice of off-label use and includes 5 criteria aimed at enhancing patient safety. \nThe forthcoming workshop in Madrid will bring together a wide range of brain researchers\, scientists\, policy-makers and healthcare professionals in order to address some of the challenges presented by off-label use in Spain. Speakers include: \n\nFrédéric Destrebecq – European Brain Council / Consejo Europeo del Cerebro\nCesar Hernandez Garcia – Spanish Agency of Medicines and Medical Devices / Agencia Española de Medicamentos y Productos Sanitarios\nAlba Ancochea Díaz – Spanish Federation of Rare Diseases / Federación Española de Enfermedades Raras\nJosé Ramón Ara Callizo – Spanish Society of Neurology / Sociedad Española de Neurología\nCelso Arango López – European College of Neuropsychopharmacology\nJavier Pardo Moreno – Rey Juan Carlos Hospital\nMarina Díaz Marsá – Foundation for Neurodegenerative Diseases Investigation\nRepresentative from Farmaindustria (TBC)\nRepresentative from the Ministry of Health (TBC)\n\nShould you be interested in attending this workshop\, please do not hesitate to reach out to us (policy@braincouncil.eu or +32 (0)2 513 27 57).
URL:https://www.braincouncil.eu/event/national-workshop-on-off-label-use-of-medicines-declaracion-sobre-buenas-practicas-del-uso-fuera-de-guia-de-medicamentos-en-espana-25th-april-2018/
END:VEVENT
END:VCALENDAR